About Us FON Media Family Office News Luxury News FON Magazine FON Newsletters FON Videos FON Social Media Events Marketplace Membership Contact Us Apply for FON+ FON+ Membership

Daring to Make a Difference in Aesthetics and Therapeutics

Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for wrinkle reduction, but also in the treatment of debilitating medical conditions.

Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.